Skip to main content

Table 2 Characteristics of the study population according to PNS types

From: Does pathological type of primary nephrotic syndrome affect serum concentrations of proprotein convertase subtilisin/kexin type 9?

Parameter

MCD (n = 11)

FSGS (n = 12)

MN (n = 27)

p-value

Age, years

31.18 ± 9.57

37.50 ± 7.97

33.33 ± 10.12

0.270

Sex (male), n (%)

59 (10%)

7 (14%)

18 (36%)

0.476

Hypertension, n (%)

1 (2%)

2 (4%)

6 (12%)

0.627

Serum PCSK9, ng/ml

301.36 ± 84.81

333.17 ± 81.82

311.70 ± 66.58

0.571

24-h urine protein, grams

6.07 ± 1.79

6.12 ± 1.71

6.68 ± 2.34

0.624

Serum creatinine, mg/dl

0.88 ± 0.24

0.95 ± 0.21

0.96 ± 0.25

0.612

eGFR, ml/min/1.73 m2

100.40 ± 32.08

89.69 ± 28.35

96.06 ± 31.74

0.705

Serum albumin, g/dl

2.27 ± 0.55

2.38 ± 0.43

2.19 ± 0.48

0.531

TC, mg/dl

321.27 ± 112.04

325.25 ± 79.75

305.48 ± 80.61

0.806

TGs, mg/dl

249.27 ± 70.63

258.25 ± 87.00

253.37 ± 90.35

0.969

LDL-C, mg/dl

219.64 ± 97.71

222.83 ± 74.51

214.89 ± 63.13

0.950

VLDL-C, mg/dl

37.18 ± 15.77

43.25 ± 24.65

33.85 ± 14.56

0.472

HDL-C, mg/dl

51.55 ± 10.52

56.00 ± 26.59

51.15 ± 15.27

0.844